Assignee
AEGERA THERAPEUTICS INC
CA·25 granted patents·11 pending applications·266 citations·filing 1996–2009
Top patents by PatentIndex Score
36 records- 0195US7579320B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2007·Granted Aug 25, 2009·41 cites·12 claims
- 0294US7589118B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2006·Granted Sep 15, 2009·40 cites·38 claims
- 0393US6300492B1Modulation of IAPs for the diagnosis and antisense treatment of proliferative diseaseAEGERA THERAPEUTICS INC·Filed 2000·Granted Oct 9, 2001·33 cites·8 claims
- 0488US7772177B2BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2006·Granted Aug 10, 2010·16 cites·19 claims
- 0588US7645741B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2007·Granted Jan 12, 2010·9 cites·47 claims
- 0687US7547724B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2006·Granted Jun 16, 2009·12 cites·15 claims
- 0787US6946544B2XAF genes and polypeptides: methods and reagents for modulating apoptosisAEGERA THERAPEUTICS INC·Filed 2002·Granted Sep 20, 2005·8 cites·11 claims
- 0884US6709866B2Methods for enhancing survival of a neuronAEGERA THERAPEUTICS INC·Filed 2000·Granted Mar 23, 2004·16 cites·19 claims
- 0983US7087584B2Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative diseaseAEGERA THERAPEUTICS INC·Filed 2001·Granted Aug 8, 2006·12 cites·8 claims
- 1082US7091333B2Antisense IAP nucleobase oligomers and uses thereofAEGERA THERAPEUTICS INC·Filed 2003·Granted Aug 15, 2006·9 cites·24 claims
- 1182US6656704B1Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 1996·Granted Dec 2, 2003·24 cites·6 claims
- 1280US7294713B2Antisense IAP oligonucleotides and uses thereofAEGERA THERAPEUTICS INC·Filed 2003·Granted Nov 13, 2007·9 cites·9 claims
- 1380US6495339B1Method of identifying a compound that modulates XAF-mediated apoptosisAEGERA THERAPEUTICS INC·Filed 2000·Granted Dec 17, 2002·3 cites·18 claims
- 1476US6541457B2Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 1998·Granted Apr 1, 2003·16 cites·18 claims
- 1574US7714003B2Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2007·Granted May 11, 2010·1 cites·21 claims
- 1674US7638620B2Antisense IAP nucleobase oligomers and uses thereofAEGERA THERAPEUTICS INC·Filed 2006·Granted Dec 29, 2009·2 cites·33 claims
- 1774US7129250B2Neuroprotective and anti-proliferative compoundsAEGERA THERAPEUTICS INC·Filed 2003·Granted Oct 31, 2006·7 cites·9 claims
- 1872US7795298B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2006·Granted Sep 14, 2010·1 cites·33 claims
- 1969US7230019B2Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2002·Granted Jun 12, 2007·3 cites·5 claims
- 2068US2010221261A1Iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2164US7700635B2Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2007·Granted Apr 20, 2010·0 cites·6 claims
- 2263US2009042953A1IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDESAEGERA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2363US2007009971A1Mammalian IAP gene family, primers, probes, and detection methodsAEGERA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2463US2006205021A1Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2560US7067281B2Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 2003·Granted Jun 27, 2006·0 cites·9 claims
- 2659US7772260B2Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2006·Granted Aug 10, 2010·0 cites·22 claims
- 2759US7741349B2Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2006·Granted Jun 22, 2010·0 cites·6 claims
- 2858US7638497B2Antisense IAP nucleobase oligomers and uses thereofAEGERA THERAPEUTICS INC·Filed 2006·Granted Dec 29, 2009·0 cites·44 claims
- 2955US2006040862A1XAF genes and polypeptides: methods and reagents for modulating apoptosisAEGERA THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 3053US6689562B1Mammalian IAP gene family, primers, probes and detection methodsAEGERA THERAPEUTICS INC·Filed 1998·Granted Feb 10, 2004·4 cites·13 claims
- 3153US2011177060A1Iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3250US2011117081A1Functionalized pyrrolidines and use thereof as iap inhibitorsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3350US2011171171A1Bridged secondary amines and use thereof as iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3448US2010203012A1Iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3546US2009179638A1Assay for identifying inhibitors of neuronal apoptotic pathwaysAEGERA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3641US2009170845A1USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAINAEGERA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AEGERA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →